Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -10.41
- Piotroski Score 3.00
- Grade Buy
- Symbol (HCWB)
- Company HCW Biologics Inc.
- Price $0.77
- Changes Percentage (8.59%)
- Change $0.06
- Day Low $0.63
- Day High $0.79
- Year High $2.52
HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata and metabolic diseases. It also develops HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. The company was incorporated in 2018 and is headquartered in Miramar, Florida.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 04/01/2025
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.76
- Trailing P/E Ratio -1.37
- Forward P/E Ratio -1.37
- P/E Growth -1.37
- Net Income $-24,994,277
Income Statement
Quarterly
Annual
Latest News of HCWB
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
HCW Biologics Inc. (HCWB) Stock Price, News, Quote & History - Yahoo Finance
HCW Biologics Inc (HCWB) stock is rising in premarket trading with high session volume. The company has signed an exclusive license agreement with WY Biotech for the development and commercialization ...
By Yahoo! Finance | 4 days ago -
HCWB Stock Price | HCW Biologics Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch
HCW Biologics Inc. is a biopharmaceutical company aiming to develop innovative immunotherapies to combat chronic inflammation and age-related diseases. Founded in 2018 by Hing C. Wong, the company is ...
By MarketWatch | 4 days ago
